Medical Developments International Limited
MDDVF
$0.37
$0.0721.99%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.22M | 25.66M | 25.30M | 25.14M | 25.10M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.22M | 25.66M | 25.30M | 25.14M | 25.10M |
| Cost of Revenue | 6.51M | 6.35M | 6.25M | 6.40M | 6.58M |
| Gross Profit | 19.71M | 19.30M | 19.05M | 18.74M | 18.52M |
| SG&A Expenses | 17.96M | 17.60M | 17.37M | 17.43M | 17.57M |
| Depreciation & Amortization | 1.91M | 1.99M | 2.07M | 2.17M | 2.29M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.39M | 25.93M | 25.69M | 26.00M | 26.44M |
| Operating Income | -160.90K | -277.20K | -389.80K | -860.30K | -1.34M |
| Income Before Tax | -244.50K | -66.00K | 115.10K | -6.47M | -13.05M |
| Income Tax Expenses | 36.60K | 41.80K | 47.20K | 3.29M | 6.53M |
| Earnings from Continuing Operations | -0.28 | -0.11 | 0.07 | -9.77 | -19.58 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -281.30K | -108.10K | 67.60K | -9.77M | -19.58M |
| EBIT | -160.90K | -277.20K | -389.80K | -860.30K | -1.34M |
| EBITDA | 1.31M | 1.26M | 1.24M | 576.40K | -172.10K |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.11 | -0.23 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.11 | -0.23 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 450.55M | 445.26M | 439.97M | 413.66M | 387.35M |
| Average Diluted Shares Outstanding | 450.55M | 450.46M | 450.38M | 424.07M | 397.76M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |